medicated feed additives

1 articles
The Motley FoolThe Motley Fool··Adé Hennis

Phibro CEO Divests $3.74M in Stock Following Robust Second-Quarter Results

Phibro CEO Jack Bendheim sold $3.74M in stock via pre-planned trading agreement following strong Q2 results driven by expanded product portfolio and strategic acquisitions.
PAHCearnings growthinsider trading